benzphetamine hydrochloride NDC 17224-672

NDC codes

FDA NDC Directory

Product NDC (as listed)17224-672Labeler and product segments. Claims need a package NDC.

Product NDC at billing width17224-0672Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
17224-672-30	17224067230	30 TABLET in 1 BOTTLE, PLASTIC (17224-672-30)Marketed from Jan 1, 2010
17224-672-60	17224067260	60 TABLET in 1 BOTTLE, PLASTIC (17224-672-60)Marketed from Jan 1, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): benzphetamine hydrochloride
Generic name (nonproprietary): benzphetamine hydrochloride
Active ingredients: Benzphetamine hydrochloride — 50 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Calvin Scott & Co., Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090968
Marketing start: Jan 1, 2010
Listing expires: Dec 31, 2026
DEA schedule: CIII
Other FDA classes: Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
Identifiers: Product ID 17224-672_f5ee265f-9765-de77-e053-2a95a90ac76fSPL ID f5ee265f-9765-de77-e053-2a95a90ac76fSPL set ID f5c3c2ed-54a2-1def-e053-2995a90ab4e3RxCUI 904368UNII 43DWT87QT7
Pharmacologic class: Sympathomimetic Amine Anorectic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N417224067230 followed by a unit qualifier and the quantity

Package 17224-0672-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Benzphetamine hydrochloride tablets, USP are indicated in the management of exogenous obesity as a short term (a few weeks) adjunct in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m2 or higher who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of Body Mass Index (BMI) based on various heights and weights. BMI is calculated by taking the patient's weight, in kilograms (kg), divided by the patient's height, in meters (m), squared. Metric conversions are as follows: pounds ÷2.2 = kg; inches × 0.0254 = meters. The limited usefulness of agents of…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 090968

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 090968
Product	Strength	Form · route	Labeler	Product NDC
Benzphetamine Hydrochloride	Benzphetamine hydrochloride 50 mg/1	TabletOral	KVK-TECH, INC	10702-040
Benzphetamine Hydrochloride	Benzphetamine hydrochloride 50 mg/1	TabletOral	Bryant Ranch Prepack	71335-0451
Benzphetamine Hydrochloride	Benzphetamine hydrochloride 50 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-541